+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 21Years +
All Genders
ID04511247

Randomized Trial Comparing Sirolimus Drug Coated Balloon to Standard Balloon Angioplasty for Treating Below the Knee Arterial Disease

Led by Concept Medical Inc. · Updated on 2025-07-03

219

Participants Needed

20

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate and compare the use of a sirolimus drug coated balloon versus standard balloon angioplasty for treating below the knee arterial disease, a condition linked to peripheral arterial disease PAD that can lead to limb loss. The study addresses concerns about safety with current paclitaxel drug coated balloons and explores sirolimus as a potentially safer alternative with promising early results in coronary arteries. Participants will receive either the MagicTouch PTA sirolimus drug coated balloon after successful plain balloon angioplasty or a placebo balloon angioplasty alongside the standard procedure. The sirolimus balloon is sized according to the initial angioplasty and applied to the lesion. The study is randomized, double-blind, and involves multiple centers. Throughout the trial, participants will be monitored for primary patency at 6 months, along with secondary outcomes including death, limb amputation, vessel thrombosis, adverse events, procedural success, revascularization need, wound healing, and pressure assessments up to 24 months. The research includes detailed follow-ups and safety checks to assess the device and procedure effectiveness over time.

CONDITIONS

Brief Title

SirolimUs CoaTed Balloon for The TrEatment of Below The Knee Arterial Disease

Research Team

E

Edward Choke

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here